Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...

The Lexus SUV that Karen Read was driving the night she was accused of mowing down her Boston cop boyfriend in 2022 is going up for auction next month. Read, 45, was at the center of a whirlwind trial ...

AI on the JVM accelerates: New frameworks like Embabel, Koog, Spring AI, and LangChain4j drive rapid adoption of AI-native and AI-assisted development in Java. Java 25 anchors a modern baseline: The ...

Moving beyond using artificial intelligence to write lesson plans and crafts emails to parents, educators are seeking out opportunities to use AI in ways that move learning forward. In this middle ...

Get started with Java streams, including how to create streams from Java collections, the mechanics of a stream pipeline, examples of functional programming with Java streams, and more. You can think ...

Save hours on data entry and formula writing with my game-changing AI tips. From the laptops on your desk to satellites in space and AI that seems to be everywhere, I cover many topics at PCMag. I've ...

Dear Heloise: Your answer to me about rinsing your teeth turned the question into a matter of time. The original question was, “Do I rinse or not?” The time you spend on your teeth is a matter of ...

As AI becomes more common and decisions more data-driven, a new(ish) form of information is on the rise: synthetic data. And some proponents say it promises more privacy and other vital benefits. Data ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

Nitika Garg does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...